Performance (Income Statement) Q3.2018 Q3.2018 Increase/(decrease) % Income Income from Sale of Goods 140,004 151,554 (11,550) (7.62) Income from Sevice 81,443 - 81,443 100.00 Cost of Sale of Goods (108,549
Owners of the parent 27.96 8.19% 41.21 34.30% (13.25) (32.15%) Jan – Mar 63 Jan – Mar 62 Increase/(Decrease) DOD BIOTECH PUBLIC COMPANY LIMITED เลขท ี111 หมู่ท ี2 ตําบลท่าจีน อําเภอเมืองสมุทรสาคร จังหวดั
. Should the loss sustained by the Client’s position in the market cause the balance in its margin account to drop below the maintenance margin , the Client will be called by his/her derivatives agent to
sales was 45.5 MB, an decrease by 4.8 MB or 9.5% y-o-y due to the Company recognized sales since 1 March 2016 onwards. On 15 October 2017, the Company has granted franchise business license under “Miyabi
, 2018 and December 31, 2019, the Company’s property, plant and equipment were valued at Baht 1,640.43 million and Baht 1,603.73 million, the decrease in property, plant and equipment caused by the Company
86.71 million, with significant operating results as follows. (Million Baht) 2019 2018 Increase /(decrease) %change Revenues from sales 789.92 666.36 123.56 18.54% Other revenues 7.58 6.76 0.82 12.13
reached 1,371.42MB, an increase of 78.15MB or 6% from 1,293.27MB in Q2 2016. This mainly resulted from a significant increase in USD zinc price and continued advantageous market premium, despite a decrease
exhibition product 1.4 In Q2-2017, The Administrative expense decrease amount 39 Million Baht equivalent 29% from previous year because the company can be collected money form customer provision for bad debt
total revenue of 186 MB which decreased from Q3/2016 by 41 MB or 18 percents which came from the decrease of export sales markets in China and Philippines Gross profit margin Q3/2017, the Company and
, which decreased by Baht 183.65 million or 17.49 % compare with the same period of 2016. The main reason was due to the decrease in Company’s average daily turnover value from Baht 5,184 million to Baht